Apollo Hospitals Q2 FY27 results: occupancy, revenue growth and bed expansion plan

The Apollo Hospitals Q2 FY27 results, published on 4 November 2026 for the quarter ended 30 September, show revenue from operations of ₹7,615 crore, up 23%, and net profit of ₹630 crore, up 32% from a year earlier. Hospital occupancy rose to 73% from 69%, and the company plans to add 5,800 beds over five years. This explainer walks through what those numbers mean, where reports differ, and what is still unknown.

Key takeaways from the Apollo Hospitals Q2 FY27 results

  • Revenue from operations: ₹7,615 crore, up 23% year on year.
  • Net profit: ₹630 crore, up 32%, as reported in most accounts. One report puts it at ₹660 crore, up 33.6%; see the note on definitions below.
  • Occupancy: 73% in the quarter versus 69% a year earlier, which Apollo linked to a richer case mix.
  • The core healthcare services business grew revenue about 23%, helped by international patients and demand for oncology and urology.
  • Expansion: a five-year plan to add 5,800 beds; a 470-bed Gurugram hospital is scheduled to begin operating in Q3 FY27.
  • EBITDA rose by nearly 29%, according to one report; an absolute figure was not given in the sources we reviewed.

Reading the headline numbers

MeasureQ2 FY27Change
Revenue from operations₹7,615 croreUp 23%
Net profit (most reports)₹630 croreUp 32% (from about ₹477 crore)
Net profit (one report)₹660 croreUp 33.6%
EBITDANot stated in absolute termsUp nearly 29% (one report)
Hospital occupancy73%Up from 69%

The two profit figures are not necessarily in conflict. Our calculation suggests the ₹630 crore figure compares with roughly ₹477 crore a year earlier, and the ₹660 crore figure with roughly ₹494 crore, which indicates the reports may be using different profit measures, for example before and after minority interests. None of the reports we reviewed says so explicitly, so we use ₹630 crore as the main figure and flag the difference. Readers needing the exact figure should check the company’s filing on the NSE or BSE websites.

What occupancy and case mix mean

Occupancy is the share of available hospital beds in use. A higher figure means the same buildings and staff serve more patients, which spreads fixed costs such as nurses, equipment and rent over more admissions. Case mix describes the type of patients treated: complex procedures such as cancer surgery, cardiac care or transplants usually bring in more revenue per bed than short, simple stays. Apollo attributed the rise to a richer case mix, and a press report said more patients came in for complex procedures.

The sources we reviewed did not give average revenue per occupied bed or a specialty-wise revenue split, so we cannot say how much of the growth came from price, volume or mix.

Specialty demand and international patients

One report said healthcare services revenue was lifted by a large jump in international patients and strong demand in oncology and urology. Medical tourism is a recognised source of high-value cases for Indian hospitals, but the sources did not quantify the international share of revenue, so we avoid putting a number on it.

Capacity expansion: what 5,800 beds involves

Apollo plans to add 5,800 beds over five years to a base of roughly 10,000 beds in India, according to a press report, including a 470-bed hospital in Gurugram due to begin operating in Q3 FY27. New hospitals usually take time to fill, and early losses, sometimes called gestational losses, can weigh on profits before occupancy builds. The investment amount and year-by-year bed additions were not provided in the sources we reviewed.

Portfolio and leadership changes

A press report also said that Apollo completed the sale of its stakes in Apollo Specialty Hospitals and Apollo Fertility Centre to Kids Clinic India Limited (Cloudnine) on 3 November 2026, and that the President and CEO of its Hospitals Division, Dr Madhu Sasidhar, steps down on 14 November 2026. We have not verified these items against company filings.

Timeline

  • Quarter ended 30 September 2026: Q2 FY27 trading period.
  • 3 November 2026: divestment of two stakes completed, per a press report.
  • 4 November 2026: Q2 results published.
  • 14 November 2026: Hospitals Division CEO due to step down, per a press report.
  • Q3 FY27: 470-bed Gurugram hospital scheduled to open.

Market context: medical tourism

Acumen Research And Consulting has no report on Indian hospitals, so we cite its Medical Tourism Market report as adjacent. It values the global market at USD 11,395 million in 2021 and projects USD 88,595 million by 2030, a compound annual growth rate of 27.4% for 2022 to 2030. Asia-Pacific is described as the dominant region and cancer treatment as the largest segment in 2021.

The page was last updated in August 2022, and its stated growth rate does not match its own endpoints; by our calculation they imply about 25.6% a year over nine years. India has no stated share in the report. We use it only to show that international patient flows are a recognised growth area, not to size Apollo’s opportunity.

Our analysis

In our assessment, the quarter shows a hospital group converting demand into profit faster than revenue: profit rose 32% while revenue rose 23%, which is consistent with operating leverage from higher occupancy. The test ahead is whether margins hold as new beds open, since new hospitals dilute occupancy before they mature. We do not have the figures to say how much dilution to expect.

What is not disclosed

  • Average revenue per occupied bed and specialty-wise revenue.
  • The investment required for the 5,800-bed plan and the timing of additions.
  • EBITDA in rupees and margin in the sources reviewed.
  • The reason for the difference between the ₹630 crore and ₹660 crore profit figures.

Risks and caveats

  • New hospitals can post early losses before reaching target occupancy.
  • Regulatory changes, such as procedure tariffs or pharmaceutical trade margins, could affect profitability.
  • Several details come from press reports and not the filing itself.
  • This article is news reporting and not investment or medical advice.

What to watch next

  • Management commentary on the earnings call.
  • Occupancy and revenue per bed at the Gurugram hospital after opening.
  • Announcements on investment and timing for the 5,800-bed plan.
  • Appointment of a new Hospitals Division chief.

General background

Company information is at Apollo Hospitals. For wider context on private capital in healthcare, see our report on India’s Q3 2026 healthcare PE and VC flows and the growth of the Indian pharmaceutical market. More in our Healthcare Services section.

Questions readers are asking about the Apollo Hospitals Q2 FY27 results

Did Apollo’s profit rise 32%?

Most reports say yes, to ₹630 crore; one says ₹660 crore, up 33.6%, probably a different profit measure.

What is occupancy?

The share of beds in use. Apollo reported 73% against 69% a year earlier.

When will the new beds arrive?

Over five years, with a 470-bed Gurugram hospital scheduled for Q3 FY27.

FAQ

What does FY27 mean?

India’s financial year 2026-27, which runs from April 2026 to March 2027; Q2 is July to September 2026.

Is the 5,800-bed plan funded?

The sources reviewed do not state the investment amount.

Who is leaving the company?

The CEO of the Hospitals Division, Dr Madhu Sasidhar, steps down on 14 November 2026, per a press report.

How we reported this: details come from press reports of Apollo Hospitals’ results published on 4 November 2026; we did not review the filing itself. Market figures are attributed to Acumen Research And Consulting. Last updated 4 November 2026. This is news reporting and not investment or medical advice.

By Simone Lamb

Simone Lamb is the editor of Medgadget.in, covering healthcare technology, medical devices, and the latest developments in digital health.

Leave a Reply

Your email address will not be published. Required fields are marked *